Annals of Oncology

News:

In Opatija, the First Central European Oncology Congress
Ann Oncol 9: 925.
[PDF] [Request Permissions]

Good and bad news ath the AIDS Conference
Ann Oncol 9: 925-926.
[PDF] [Request Permissions]

Maryland law mandates insurance converage for clinical trials
Ann Oncol 9: 926.
[PDF] [Request Permissions]

Soros vs. Clinton
Ann Oncol 9: 926.
[PDF] [Request Permissions]

Harsh criticism of IRBs
Ann Oncol 9: 926-927.
[PDF] [Request Permissions]

Perhaps not everyone knows that...
Ann Oncol 9: 927-928.
[PDF] [Request Permissions]

Editorial:

B. L. Weber

Managing cancer risk without adequate data: A necessary evil
Ann Oncol 9: 929-931.
[PDF] [Request Permissions]

J.T. Thigpen

If and when? The role of chemotherapy in locally advanced carcinoma of the cervix
Ann Oncol 9: 933-935.
[PDF] [Request Permissions]

M. D'Incalci

Some hope from marine natural products
Ann Oncol 9: 937-938.
[PDF] [Request Permissions]

Book reviews:

Z. S. Pavletic

Book review
Ann Oncol 9: 932.
[PDF] [Request Permissions]

V. Spataro

Book review
Ann Oncol 9: 936.
[PDF] [Request Permissions]

Special articles:

F. Eisinger, N. Alby, A. Bremond, J. Dauplat, M. Espié, P. Janiaud, F. Kuttenn, J.-P. Lebrun, J.-P. Lefranc, J. Pierret, H. Sobol, D. Stoppa-Lyonnet, D. Thouvenin, H. Tristant, and J. Feingold

Recommendations for medical management of hereditary breast and ovarian cancer: The French National Ad Hoc Committee^*
Ann Oncol 9: 939-950.
[Abstract] [PDF] [Request Permissions]

Review:

A. Wobst, R. A. Audisio, M. Colleoni, and J. G. Geraghty

Oesophageal cancer treatment: Studies, strategies and facts
Ann Oncol 9: 951-962.
[Abstract] [PDF] [Request Permissions]

Review on evidence-based cancer medicine:

M. W. Enkin and A. R. Jadad

Using anecdotal information in evidence-based health care: Heresy or necessity?
Ann Oncol 9: 963-966.
[Abstract] [PDF] [Request Permissions]

Arena:

C.-H. Köhne, M. Lorenz, and R. Herrmann

Colorectal cancer liver metastasis: Local treatment for a systemic disease?
Ann Oncol 9: 967-971.
[PDF] [Request Permissions]

Commentary:

A. Goldhirsch, A. S. Coates, M. Castiglione-Gertsch, and R. D. Gelber

New treatments for breast cancer: Breakthroughs for patient care or just steps in the right direction?
Ann Oncol 9: 973-976.
[Abstract] [PDF] [Request Permissions]

Original articles:

G. Zanetta, A. Lissoni, A. Pellegrino, C. Sessa, N. Colombo, D. Gueli-Alletti, and C. Mangioni

Neoadjuvant chemotherapy with cisplatin, ifosfamide and paclitaxel for locally advanced squamous-cell cervical cancer
Ann Oncol 9: 977-980.
[Abstract] [PDF] [Request Permissions]

E. Izbicka, R. Lawrence, E. Raymond, G. Eckhardt, G. Faircloth, J. Jimeno, G. Clark, and D. D. Von Hoff

In vitro antitumor activity of the novel marine agent, Ecteinascidin-743 (ET-743, NSC-648766) against human tumors explanted from patients
Ann Oncol 9: 981-987.
[Abstract] [PDF] [Request Permissions]

M. Ghielmini, E. Colli, E. Erba, D. Bergamaschi, S. Pampallona, J. Jimeno, G. Faircloth, and C. Sessa

In vitro schedule-dependency of myelotoxicity and cytotoxicity of Ecteinascidin 743 (ET-743)
Ann Oncol 9: 989-993.
[Abstract] [PDF] [Request Permissions]

N. L. Berinstein, A. J. Grillo-Lopez, C. A. White, I. Bence-Bruckler, D. Maloney, M. Czuczman, D. Green, J. Rosenberg, P. McLaughlin, and D. Shen

Association of serum Rituximab (IDEC-C2B8) concentration and anti-tumor response in the treatment of recurrent low-grade or follicular non-Hodgkin's lymphoma
Ann Oncol 9: 995-1001.
[Abstract] [PDF] [Request Permissions]

N. Touroutoglou, D. Gravel, M. N. Raber, W. Plunkett, and J. L. Abbruzzese

Clinical results of a pharmacodynamically-based strategy for higher dosing of gemcitabine in patients with solid tumors
Ann Oncol 9: 1003-1008.
[Abstract] [PDF] [Request Permissions]

Ch. Kurowski and F. Berthold

Presence of classical multidrug resistance and P-glycoprotein expression in human neuroblastoma cells
Ann Oncol 9: 1009-1014.
[Abstract] [PDF] [Request Permissions]

Clinical case:

C. Als, H. Laeng, T. Cerny, J. A. Kinser, H. Rösler, and R. Häusler

Primary cervical malignant teratoma with a rib metastasis in an adult: Five-year survival after surgery and chemotherapy: A case report with a review of the literature
Ann Oncol 9: 1015-1022.
[Abstract] [PDF] [Request Permissions]

Short report:

Z. S. Pavletic, P. J. Bierman, J. M. Vose, M. R. Bishop, C. D. Wu, J. L. Pierson, J. P. Kollath, D. D. Weisenburger, A. Kessinger, and J. O. Armitage

High incidence of relapse after autologous stem-cell transplantation for B-cell chronic lymphocytic leukemia or small lymphocytic lymphoma
Ann Oncol 9: 1023-1026.
[Abstract] [PDF] [Request Permissions]

M. P. Martelli, M. Martelli, E. Pescarmona, V. De Sanctis, V. Donato, F. Palombi, E. Todisco, E. A. Rendina, F. M. Pau, and F. Mandelli

MACOP-B and involved field radiation therapy is an effective therapy for primary mediastinal large B-cell lymphoma with sclerosis
Ann Oncol 9: 1027-1029.
[Abstract] [PDF] [Request Permissions]

S. Mani, J. W. Kugler, D. F. Sciortino, J. C. Garcia, R. H. Ansari, R. Humerickhouse, F. Michelassi, M. C. Posner, K. L. Shulman, R. L. Schilsky, M. List, E. E. Vokes, and S. Benner

Phase II trial of uracil/tegafur (UFT) plus leucovorin in patients with advanced pancreatic carcinoma: A University of Chicago phase II consortium study
Ann Oncol 9: 1035-1037.
[Abstract] [PDF] [Request Permissions]

Articles:

G. Fountzilas, A.-M. Dimopoulos, C. Papadimitriou, A. Kalogera-Fountzila, G. Aravantinos, D. Bafaloukos, A. Athanassiades, C. Nicolaides, A. Keramopoulos, N. Pavlidis, P. Kosmidis, and D. Skarlos

First-line chemotherapy with paclitaxel by three-hour infusion and carboplatin in advanced breast cancer (final report): A phase II study conducted by the Hellenic Cooperative Oncology Group
Ann Oncol 9: 1031-1034.
[Abstract] [PDF] [Request Permissions]

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.